Sep 2026
Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.
Both fractional doses of 17DD yellow fever vaccine were non-inferior to full doses in inducing initial seroconversion and support the use of fractional dose yellow fever vaccines among young children for outbreak response during supply shortages.
Reena H. Doshi, Irene Lubega, Pierre Muhoza et al.
· The Lancet · 0 citations